This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

Register by January 24 to save up to $1200

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA
Book Now
Menu
Book

Rebecca Goldman, PhD
Associate Director, Formulations at Tessera Therapeutics
Speaker

Profile

Rebecca Goldman has over 11 years of experience in the lipid nanoparticle field. She received her PhD in Chemical Engineering at Carnegie Mellon University in the Whitehead Lab. After graduate school she joined the company Translate Bio and afterwards Sanofi through the company acquisition, where she led formulation development for mRNA vaccine applications. Currently, Rebecca is at Tessera Therapeutics where she leads a formulation team focused on extrahepatic LNP delivery.

Agenda Sessions

  • Delivery of RNA Gene Writers in vivo using Lipid Nanoparticles for Correction of Sickle Cell Mutation in HSCs and generation of CAR-T Cells.

    , 2:30pm
    View Session

At this event

Prev
Next
Tyler Goodwin, PhD
Head of Delivery Technologies
Tune Therapeutics

See Rebecca at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now